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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYMembers of the miR-290 family are the most abundantly expressed microRNAs (miRNAs) in mouse embryonic stem cells (ESCs). They
regulate aspects of differentiation, pluripotency, and proliferation of ESCs, but themolecular program that they control has not been fully
delineated. In the absence ofDicer, ESCs fail to expressmaturemiR-290miRNAs andhave selective aberrant overexpressionofHoxa,Hoxb,
Hoxc, and Hoxd genes essential for body plan patterning during embryogenesis, but they do not undergo a full differentiation program.
Introduction of maturemiR-291 into DCR/ ESCs restoresHox gene silencing. This was attributed to the unexpected regulation of Poly-
comb-mediated gene targeting bymiR-291.We identified themethyltransferase Ash1l as a pivotal target ofmiR-291mediating this effect.
Collectively, our data shed light on the role ofDicer in ESChomeostasis by revealing a facet ofmolecular regulationby themiR-290 family.INTRODUCTION
Mouse embryonic stem cells (ESCs) that lack microRNAs
(miRNAs) due to Dicer1 or Dgcr8 deficiency do not prolifer-
ate well and display severe differentiation defects (Kanello-
poulou et al., 2005; Murchison et al., 2005; Wang et al.,
2008). The most highly expressed miRNAs in mouse ESCs
belong to the miR-290 family, a cluster of nine miRNAs
(also referred to as miR-290295), six of which share the
same ‘‘seed’’ sequence (Houbaviy et al., 2003). The ortholo-
gous human families are miR-302 and miR-371 (Suh et al.,
2004). In mice, the miR-290 cluster is transcribed from a
single locus on chromosome 7 by the core ESC transcrip-
tional network (Marson et al., 2008) and can rescue defec-
tive proliferation in ESCs that lack miRNAs (Wang et al.,
2008).While the importance of themiR-290 family is clear,
how it contributes to the gene expression program in ESCs
is not fully known.
The Hox family of transcription factors governs the ante-
rior to posterior axial body plan of vertebrates (Pearson
et al., 2005). Inmouse and human, theHox genes are found
in four chromosomal clusters (A, B, C, andD).Hox genes are
transcriptionally inactive in ESCs due to the action of Poly-
comb repressive complexes (PRC) (Bracken et al., 2006; Lee
et al., 2006), but the role, if any, of miRNAs in this process
has not been established.
Polycomb group (PcG) proteins are transcriptional re-
pressors that regulate embryonic development and func-
tion in ESC pluripotency and induced pluripotent stem
cell (iPSC) generation (Bernstein et al., 2006; Boyer et al.,
2006; Onder et al., 2012). There are two Polycomb com-Stem Cellplexes, PRC1 and PRC2, that differ biochemically (Di Croce
and Helin, 2013). PRC2 catalyzes the trimethylation of his-
tone H3K27 (H3K27me3), which is recognized by PRC1,
although PRC1 can be recruited to chromatin indepen-
dently of PRC2 and H3K27me3 (Schwartz and Pirrotta,
2014). Overall, despite extensive study, it remains unclear
how Polycomb repressive chromatin domains are estab-
lished in ESCs and reversed during development to allow
the expression of differentiation genes.
Both PcG proteins and Dicer are required for ESC prolif-
eration, pluripotency, and differentiation and play key
roles in development, but the interplay between the two
has not been studied. We observed that in DCR/ ESCs,
Hox genes, which are Polycomb targets, were upregulated,
which in turn led to the finding that miR-290 is required
for efficient gene repression involving Polycomb targeting.RESULTS
Collectively, miR-290 miRNAs with the seed sequence 50-
AAGUGC-30 account for 70% of mature miRNAs ex-
pressed in ESCs, and these are undetectable in DCR/
ESCs by Nanostring analysis (Figure S1A) (Calabrese et al.,
2007; Houbaviy et al., 2003). To determine the role of the
miR-290 family in ESC gene regulation, we transfected a
synthetic miR-291a-3p mimic (abbreviated as miR-291
hereafter) into DCR/ ESCs and performed transcriptome
sequencing analysis (RNA-seq). Our RNA-seq analysis re-
vealed that genes belonging to the Hoxa, Hoxb, and Hoxd
gene clusters were among the most differentially expressedReports j Vol. 5 j 971–978 j December 8, 2015 j ª2015 The Authors 971
Figure 1. miR-291 Restores Hox Gene
Repression in DCR/ ESCs
(A) Genome browser screenshot of the RNA-
seq reads aligning to the Hoxa and Cdkn1a
loci in DCRfl/fl and DCR/ ESCs ± miR-291.
(B) Sylamer analysis of motifs enriched in
the 30 UTRs of differentially expressed
mRNAs after transfection with miR-291.
Vertical red dashed lines mark the cut-off for
log2-fold change of 2, 1, and 0 as indicated.
(C) qRT-PCR for representative Hox genes, in
DCRfl/fl and DCR/ cells before and after
transfection with miR-291. Each bar repre-
sents the mean ± SD of three independent
experiments.
See also Figure S1.in DCR/ ESCs (Figure 1A; Table S1). Transfection of miR-
291 dramatically restoredHox gene silencing (Figure 1A). In
contrast, previously characterized miR-290 targets, such as
Cdkn1a and Rbl2 (Wang et al., 2008) were modestly regu-
lated (Figures 1A and S1B).
To demonstrate that miR-291 transfection mimics phys-
iological levels, we measured its relative expression by
qRT-PCR. miR-291 levels in transfected DCR/ ESCs
were 6-fold higher than in untransfected DCRfl/fl cells (Fig-
ure S1C). Considering that miR-291a is one of six miRNAs
with the same seed sequence, some of which are more
highly expressed in ESCs (Figure S1A), themiR-291 concen-
tration after transfection in DCR/ ESCs was actually at or
below endogenous aggregate levels for the whole miR-290
family. Thus the observed repression of Hox genes was not
due to overexpression ofmiR-291. In addition, transfection
of miR-291 had little effect on the transcriptome of DCRfl/fl
cells—only four genes exhibited a greater than 2-fold
change (data not shown). Also, the only motif enriched
in the 30 UTRs of transcripts regulated by miR-291 by Syl-
amer analysis (van Dongen et al., 2008) was complemen-
tary to the miR-290 seed sequence, thereby indicating
specificity.
We confirmed the suppression of representative Hox
genes, including Hoxa7, Hoxa10, Hoxb9, and Hoxd9 upon
miR-291 transfection by qRT-PCR (Figure 1C). Similarly,
transfection of miR-294, another member of the miR-290972 Stem Cell Reports j Vol. 5 j 971–978 j December 8, 2015 j ª2015 The Afamily, potently reduced Hox gene transcripts (Figure S1D).
Thus, the miR-290 family is a regulator of Hox gene expres-
sion in ESCs.
Hox genes are activated during ESC differentiation. How-
ever, Hox gene overexpression did not appear to be the
consequence of a broad program of differentiation of
DCR/ ESCs. For example, we did not observe downregu-
lation of the core pluripotency factors Oct4, Sox2, Klf4, and
Nanog nor upregulation of differentiation markers such as
Brachyury, Fgf5, Gata4, and Gata6 (Figures 2A and S2).
Since RNA-seq and qRT-PCR analyses cannot provide in-
formation at the single-cell level, we performed RNA fluo-
rescence in situ hybridization (RNA-FISH) for Hoxa9 to
assess whether the observed upregulation was due to a
few cells expressing high levels of Hox transcripts or a gen-
eral characteristic of DCR/ ESCs. The RNA-FISH analysis
showed more Hoxa9 transcripts in the majority of DCR/
ESCs, while the housekeeping gene Hprt was not differen-
tially expressed (Figure 2B). TheDAPI nuclear signal demar-
cates individual cells.
To exclude that Hox derepression was due to prolonged
culture of DCR/ ESC clones, we deleted Dicer acutely us-
ing a tamoxifen-inducible Cre DCRfl/fl ES cell line (DCRfl/fl;
R26CreERT2) (Nesterova et al., 2008). Three days after
tamoxifen (4OHT) addition, DICER protein was dramati-
cally reduced, and 9 days later ARGONAUTE2 (AGO2),
which is destabilized in the absence of mature miRNAsuthors
Figure 2. Homeobox Genes Are Transcrip-
tionally Upregulated in DCR/ ESCs
(A) Scatterplot of normalized read values of
DCRfl/fl versus DCR/ ESCs from an RNA-seq
experiment. Highlighted aregenes belonging
to the Hox clusters, the core pluripotency
factors Oct4, Sox2, Klf4, Nanog, and Lin28a
and two miR-290 targets, Cdkn1a and Lats2.
Red dashed lines indicate the 2-fold change
cut-off for differentially expressed genes
(dots in red).
(B) RNA-FISH for Hoxa9 (green) and Hprt
(red) in DCRfl/fl and DCR/ ESCs (scale bar,
10 mm). Nuclei are counterstained by DAPI.
(C) qRT-PCR for representative Hox genes in
DCRfl/fl;R26CreERT2 cells with or without
the addition of tamoxifen (4OHT). (Bars
represent mean ± SD of three independent
experiments.) Inset shows western blot
analysis of DICER and AGO2 protein levels.
ACTIN is shown as a loading control.
(D) Normalized luciferase levels after
transfection of DCR/ ESCs with indicated
vectors ± miR-291 or miR-293. Values were
normalized to the no miRNA control. Bars
represent mean of two (Hoxa10-UTR and
Hoxd9-UTR) or one (Cdkn1a and Lats2) in-
dependent experiments.
(E) qRT-PCR for representative Hox genes
using intronic primers.
(F) ChIP-qPCR of RNA POL II at Hoxa10,
Hoxd9, and Lin28a promoters (bars repre-
sent mean ± SD of eight independent ex-
periments). Data are represented as fold
change of DCR/ over DCRfl/fl signal.
See also Figure S2.(Martinez and Gregory, 2013), was also decreased (Fig-
ure 2C inset), while Hoxa10 and Hoxd9 transcripts were
upregulated.
To test whether miR-291 regulated Hox mRNA stability,
we inserted the 30 UTR of Hoxa9 and Hoxd10 downstream
of a luciferase reporter. We observed no effect on luciferase
expression when Hox reporter vectors were cotransfected
with miR-291 in DCR/ ESCs in contrast to the observed
repression when bona fide direct targets such as Cdkn1a
and Lats2 30 UTRs were tested (Figure 2D). Cotransfection
with miR-293 (a non-‘‘seed’’-containing miRNA from the
miR-290 cluster) was used as a negative control. These ob-
servations suggest that the effect of miR-291 on Hox genes
is indirect and likely transcriptional; we therefore per-
formed qRT-PCR for Hoxa9 and Hoxd10 using intronic
primers. Unspliced primary transcripts, a proxy of ongoing
transcription,were upregulated inDCR/ESCs (Figure 2E).
In addition, RNA polymerase (POL) II occupancy at Hox
gene promoters was higher in DCR/ compared to DCRfl/flStem CellESCs (Figure 2F). Thus, the increased Hox gene expression
appeared to be due to transcriptional regulation.
We next examined howmiRNAs could regulateHox gene
transcription. In ESCs, Hox gene promoters are bivalent
(Bernstein et al., 2006; Boyer et al., 2006), with both acti-
vating and repressive histone H3 modifications at lysines
4 and 27 (H3K4me3 and H3K27me3, respectively), but
are maintained transcriptionally silent by PcG proteins.
Thus, we performed chromatin immunoprecipitation fol-
lowed by deep sequencing (ChIP-seq) to determine the
localization of the core PRC2 components SUZ12 and
JARID2 as well as theH3K27me3mark catalyzed by this ho-
loenzyme. Using ChIP-seq, and ChIP-qPCR for validation,
we found that SUZ12, JARID2, and H3K27me3 were all
reduced at Hox gene promoters in DCR/ ESCs (Figures
3A and 3B). The Lin28a promoter, which is not a Polycomb
target, was used as a negative control. We also observed a
reduction in the association of the PRC1 subunit RING1b
at Hox loci (Figure S3A).Reports j Vol. 5 j 971–978 j December 8, 2015 j ª2015 The Authors 973
Figure 3. Defect in PcG Protein Recruit-
ment in DCR/ ESCs.
(A) ChIP-qPCR analysis of SUZ12, JARID2,
H3K27me3 at Hoxa10 and Hoxd9 promoters
and the Lin28a promoter as a control (bars
represent mean ± SD of at least five inde-
pendent experiments). Data are represented
as fold change of DCRfl/fl over DCR/
signal.
(B) Genome browser screenshot of the
reads aligning to the Hoxd locus after
ChIP with anti-SUZ12, anti-JARID2, or anti-
H3K27me3 antibodies.
(C) Line plot depicts distribution of
H3K27me3 (left), SUZ12 (middle), and
JARID2 (right) localization at TSS ± 5 kb of
all RefSeq genes.
(D) Cumulative fraction plot of the total
number of expressed genes (black line) and
genes that have a SUZ12 peak in DCRfl/fl ESCs
(green line) sorted by log2-fold change of
the reads in DCRfl/fl versus DCR/ ESCs. P
value was calculated using a Kolmogorov-
Smirnov test.
(E) Western blot showing the levels of EZH2,
SUZ12, JARID2, and EED. Numbers below
each lane represent the signal of each band
normalized to the signal from tubulin. The
normalized signal from the DCRfl/fl lysates is
set to 1.
(F) ChIP-qPCR for SUZ12 in DCRfl/fl and
DCR/ cells before and after transfection
with miR-291. Bars represent mean ± SD of
three independent experiments.
(G) Same as (D), but the log2-fold change of
the reads in DCR/ cells ± miR-291 is
plotted. P value was calculated using a
Kolmogorov-Smirnov test.
See also Figure S3.Furthermore, we observed a global reduction in Poly-
comb at sites throughout the genome. In the absence of
Dicer, there was a marked reduction of SUZ12, JARID2,
and H3K27me3 at transcriptional start sites (TSSs) (Fig-
ure 3C). To assess the impact of reduced Polycomb accumu-
lation on the transcriptome of DCR/ ESCs, we analyzed
differentially expressed genes and found there was a signif-
icant enrichment for SUZ12 targets in the genes upregu-
lated in DCR/ ESCs (Figure 3D). However, not all PRC2
targets with reduced JARID2, SUZ12, and H3K27me3
were transcriptionally upregulated (Figures S3D and S4D).974 Stem Cell Reports j Vol. 5 j 971–978 j December 8, 2015 j ª2015 The ASUZ12, JARID2, EED, and EZH2 protein levels were not
decreased nor were mRNA levels for other PcG proteins
(Figures 3E and S3C). Thus, it seems that deletion of Dicer1
affects the targeting of PcG proteins to cognate genomic lo-
cations rather than the expression levels of PcG proteins.
Since Hox genes are prototypical PcG targets in many or-
ganisms (Boyer et al., 2006; Lewis, 1978), we focused on
their regulation as a reflection of overall PcG function.
We found that miR-291 significantly increased Suz12 bind-
ing at the Hoxa10 and Hoxd9 TSSs in DCR/, but not in
DCRfl/fl ESCs (Figure 3F). Moreover, miR-291 transfectionuthors
in DCR/ ESCs significantly reduced Suz12 target gene
transcripts (Figure 3G).
To further investigate the mechanism of miR-291 regula-
tion of PcG recruitment at TSSs and Hox gene repression,
we examined the differential expression of candidate regu-
latory genes from RNA-seq analyses. Interestingly, many
Trithorax group genes, which are known antagonists of
Polycomb, such as mixed lineage leukemia (Mll) were upre-
gulated in DCR/ ESCs and reduced upon miR-291 trans-
fection (Figure S4A). Since we observed no increase in
H3K4me3, catalyzed by MLL proteins, at Hox loci (Fig-
ure S4B) or globally (Figure S4C), MLL proteins, despite
their potentially important upregulation, are not likely
responsible for antagonizing PRC recruitment in DCR/
ESCs. We also investigated other prominently deregulated
genes, such as the histone acetyltransferase Kat2b and
Mllt6, which probably helps catalyze H3K79 methylation
(Mohan et al., 2010). However, inhibition by garcinol of
Kat2b or knockdown of Mllt6 did not restore Hox gene
repression (data not shown).
However, we discovered that miR-291 regulated another
Trithorax group protein, the H3K36 methyltransferase
Ash1l. It was recently reported that H3K36me3 deposition
atHox loci occurs independently of transcription via the ac-
tion of ASH1L and is sufficient to evict Polycomb (Miyazaki
et al., 2013).We observed thatAsh1l transcripts and protein
were suppressed by miR-291 (Figures 4A and 4D). Since
there is a predicted miR-290 site in the 30 UTR of Ash1l
(Lewis et al., 2005), we cloned it into a luciferase reporter
vector and assessed its activity upon miR-291 cotransfec-
tion. We found that the Ash1l 30 UTR decreased luciferase
levels when cotransfected with miR-291 (Figure 4B).
ASH1L was also significantly enriched at Hox coding re-
gions in DCR/ ESCs by ChIP (Figure 4C). We then tested
whether Ash1l knockdowns could silence Hox genes in the
absence of Dicer. Although the Ash1l knockdown was par-
tial, it significantly reduced Hoxa10 and Hoxd9 expression
in DCR/ ESCs (Figures 4D and 4E). Notably, the effect
of Ash1l knockdown was less dramatic than usually
observed with miR-291, which could reflect either the par-
tial knockdown or the possibility of additionalmiR-291 tar-
gets. Since miRNAs usually target a large number of genes
to synergistically induce desired cellular phenotypes, it is
likely that a combination of factors, including Ash1l, leads
to transcriptional derepression and Polycomb eviction at
Hox genes and other Polycomb sites.DISCUSSION
Dicer is essential for the ESC phenotype, although expres-
sion of the core pluripotency factors is maintained in
DCR/ ESCs, indicating that miRNAs may control addi-Stem Celltional determinants of pluripotency. We found that genes
associated with ESC differentiation, specifically the Hox
family, were overexpressed in DCR/ ESCs. First, we
observed that Hox genes were regulated by miR-290, the
most abundantly expressed miRNA family in undifferenti-
ated ESCs. Second, we could attribute this effect to reduced
localization of PRC2. This is important because PcG pro-
teins maintain ESCs in a pluripotent state by silencing
Hox and other ‘‘bivalent’’ differentiation genes primed for
transcription (Bernstein et al., 2006; Boyer et al., 2006).
Loss of Dicer altered PRC2 recruitment throughout the
genome, illustrating the crucial role of miRNAs in govern-
ing the targeting of this silencing complex. Consistently,
a significantnumber of PcG target geneswere transcription-
ally activated in DCR/ ESCs (Figures 3D and S4D). How-
ever, some genes lost Polycomb binding but were not
transcriptionally activated (Figures S3D and S4D). Hence,
PRC removal from chromatin is not always a secondary ef-
fect of transcriptional activation of differentiation genes in
DCR/ ESCs (Riising et al., 2014). In fact, there is only 20%
overlap of genes activateduponDicer deletion and retinoic-
acid-induced differentiation, and most of these genes are
Polycomb targets (Figure S4D). Moreover, we found that
reduction of PcG proteins at genomic loci could not be
attributed to changes in the expression levels of PRC1 and
PRC2 subunits (Figures 3E and S3C). Rather,miR-290mem-
bers regulate the targeting of PRC1 andPRC2 to appropriate
loci in ESCs to maintain their ‘‘stemness.’’
The miR-290 cluster has been previously implicated in
regulation of de novomethyltransferases (Dnmts) (Sinkko-
nen et al., 2008), and DNA methylation may affect PcG
localization (Reddington et al., 2013). It will be interesting
to see if the observed reduction in Polycomb binding is
partially due to loss of proper DNAmethylation in DCR/
ESCs and redistribution of PRC components across the
genome.
We found that miR-291 repressed Ash1l, which can acti-
vateHox genes by evicting Polycomb during differentiation
(Miyazaki et al., 2013; Tanaka et al., 2011). Ash1l is a pre-
dicted target ofmiR-291, whichwe validated using reporter
assays. We observed that knockdown of Ash1l reduced Hox
gene expression in DCR/ ESCs, suggesting that reduction
ofH3K36methylation is sufficient to partially suppressHox
gene transcription. Thus, our data reveal a circuit ofmiRNA
control of ESC gene expression through Ash1l and target-
ing of PcG proteins.
It has been reported that the miR-290 family enhances
generation and quality of mouse and human iPS cells,
but themechanism is not fully understood (Anokye-Danso
et al., 2011; Judson et al., 2009; Liao et al., 2011; Miyoshi
et al., 2011). PRC2 is also required for reprogramming (On-
der et al., 2012; Pereira et al., 2010), and similar to DCR/
ESCs, PRC2 mutant ESCs fail to differentiate (Pasini et al.,Reports j Vol. 5 j 971–978 j December 8, 2015 j ª2015 The Authors 975
Figure 4. Histone Methyltransferase
Ash1l Is a Target of miR-291 and Regu-
lates Hox Gene Expression
(A) Relative expression of Ash1l in DCRfl/fl
and DCR/ ESCs ± miR-291.
(B) Normalized luciferase levels after
transfection of DCR/ ESCs with indi-
cated vectors ± miR-291. Values were
normalized to the no miRNA control. Bars
represent mean ± SD of three independent
experiments.
(C) ChIP-qPCR analysis of ASH1L enrichment
at indicated loci. Data are represented as
fold change of DCR/ over DCRfl/fl signal.
(D) Relative expression of Hoxa10, Hoxd9,
and Ash1l in DCR/ ESCs after transfection
with the indicated miRNA or siRNA. Bars
represent mean ± SD of three independent
experiments. Data are represented as fold
change compared to DCR/ ESCs.
(E) Western blot showing the levels of
ASH1L in DCRfl/fl and DCR/ ESCs mock
transfected or transfected with miR-291 or
siRNAs targeting Ash1l (siAsh1l). Numbers
below each lane indicate the signal of each
band normalized to the signal from HSP90.
The normalized signal for DCRfl/fl is set to 1.
(F) Schematic model of miR-290 regulation
of PcG targeting and Ash1l.
See also Figure S4.2007). This could imply that these two phenotypes may be
related, since we show that PcG targeting is influenced by
miR-290 miRNAs in ESCs. Thus, this regulatory mecha-
nism may affect not only Hox genes but also other factors
important for pluripotency. It will be interesting to explore
whether there is a broader role of this gene regulatory cir-
cuit in pluripotency and differentiation in various types
of stem cells and cancer.EXPERIMENTAL PROCEDURES
Cell Culture and Transfections
All animal work was done in accordance with the guidelines of the
Institutional Animal Care and Use Committee. DCRfl/fl ESCs were
derived from days post-coitum (DPC) 3.5 embryos. DCR/ clones
were isolated after Adeno-Cre (Harvard Gene Therapy). For acute
Dicer deletion, cells were treated with 2.5 mM of 4OHT (Sigma).976 Stem Cell Reports j Vol. 5 j 971–978 j December 8, 2015 j ª2015 The APrior to transfections, harvesting of cells for RNA, protein, or
ChIP, mouse embryonic fibroblasts (MEFs) were removed using
MEF removal microbeads (Miltenyi Biotech). For detailed descrip-
tion, please see the Supplemental Experimental Procedures.Protein Analyses, ChIP, and ChIP-Seq
ChIP was performed according to published protocols. A detailed
description is provided in the Supplemental Experimental Proce-
dures. All P values were calculated with an unpaired Student’s
t test unless otherwise stated. * p < 0.05; ** < 0.01; *** p < 0.001.
Western blotting was performed as previously described. West-
ern blots (WBs) for PRC2 components were analyzed using the
Li-Cor imaging system and software.RNA Analyses
RNA was prepared with Trizol (Invitrogen) or RNAzol (MRC) re-
agent according to the manufacturer’s instructions. All primersuthors
were designed using the Primer 3 software (Steve Rozen, Helen J.
Skaletsky, http://biotools.umassmed.edu/bioapps/primer3_www.
cgi), and sequences are provided in Table S2. RNA-seq libraries
were prepared using the TruSeq Stranded mRNA Sample Prep Kit
or TruSeq RNA Sample Preparation Kit v2 and analyzed on a GAIIx
genome analyzer (Illumina). For RNA FISH, labeled probes (Quan-
tigene RNAVIEW ISH probes) were purchased from Panomics and
used according to themanufacturer’s instructions (see also Supple-
mental Experimental Procedures). miRNA abundance was quanti-
fiedwith the nCountermiRNAExpressionAssay (Nanostring Tech-
nologies) or with individual Taqman miRNA assays (ABI).
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